Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalNo recent work listed

Dongnan Ping

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5032994259. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. Sirtuin4 impacts mitochondrial homeostasis in pancreatic cancer cells by reducing the stability of AlkB homolog 1 via deacetylation of the HRD1-SEL1L complex. Co-author DOI 10.1016/j.bbagrm.2023.194941↗
  2. Scaffold-based three-dimensional cell model of pancreatic cancer is more suitable than scaffold-free three-dimensional cell model of pancreatic cancer for drug… Co-author DOI 10.1007/s10616-022-00553-z↗
  3. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation. Co-author DOI 10.1038/s41419-020-03019-2↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liping Cao · 3 shared papers, 2020–2023 · strength 0.51
  2. Shengnan Jia · 2 shared papers, 2020–2022 · strength 0.32
  3. Dafei Xie · 1 shared paper, 2022 · strength 0.20
  4. Shengnan Jia · 1 shared paper, 2023 · strength 0.18
  5. Chaolei Zhang · 1 shared paper, 2023 · strength 0.18
  6. Xiaofan Pu · 1 shared paper, 2023 · strength 0.18
  7. Guoping Ding · 1 shared paper, 2020 · strength 0.12
  8. Xiaodong Xu · 1 shared paper, 2020 · strength 0.12
  9. Dan Li · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.